These are the sources and citations used to research Cancer Immunotherapy. This bibliography was generated on Cite This For Me on

  • Journal

    Burnet, F.

    IMMUNOLOGICAL ASPECTS OF MALIGNANT DISEASE

    1967 - The Lancet

    In-text: (Burnet, 1967)

    Your Bibliography: Burnet, F. (1967). IMMUNOLOGICAL ASPECTS OF MALIGNANT DISEASE. The Lancet, [online] 289(7501), pp.1171-1174. Available at: http://10.1016/s0140-6736(67)92837-1.

  • Journal

    Chen, D. and Mellman, I.

    Oncology Meets Immunology: The Cancer-Immunity Cycle

    2013 - Immunity

    In-text: (Chen and Mellman, 2013)

    Your Bibliography: Chen, D. and Mellman, I. (2013). Oncology Meets Immunology: The Cancer-Immunity Cycle. Immunity, [online] 39(1), pp.1-10. Available at: http://10.1016/j.immuni.2013.07.012.

  • Journal

    Eberlein, T.

    Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy

    2012 - Yearbook of Surgery

    In-text: (Eberlein, 2012)

    Your Bibliography: Eberlein, T. (2012). Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy. Yearbook of Surgery, [online] 2012, pp.349-350. Available at: http://10.1016/j.ysur.2011.09.015.

  • Journal

    Farkona, S., Diamandis, E. P. and Blasutig, I. M.

    Cancer immunotherapy: the beginning of the end of cancer?

    2016 - BMC Medicine

    In-text: (Farkona, Diamandis and Blasutig, 2016)

    Your Bibliography: Farkona, S., Diamandis, E. and Blasutig, I. (2016). Cancer immunotherapy: the beginning of the end of cancer?. BMC Medicine, [online] 14(1). Available at: http://10.1186/s12916-016-0623-5.

  • Journal

    Fenoglio, D., Traverso, P., Parodi, A., Kalli, F., Zanetti, M. and Filaci, G.

    Generation of more effective cancer vaccines

    2013 - Human vaccines & immunotherapeutics

    In-text: (Fenoglio et al., 2013)

    Your Bibliography: Fenoglio, D., Traverso, P., Parodi, A., Kalli, F., Zanetti, M. and Filaci, G. (2013). Generation of more effective cancer vaccines. Human vaccines & immunotherapeutics, [online] 9(12), pp.2543-2547. Available at: http://10.4161/hv.26147.

  • Journal

    Finke, J., Ferrone, S., Frey, A., Mufson, A. and Ochoa, A.

    Where have all the T cells gone? Mechanisms of immune evasion by tumors

    1999 - Immunology Today

    In-text: (Finke et al., 1999)

    Your Bibliography: Finke, J., Ferrone, S., Frey, A., Mufson, A. and Ochoa, A. (1999). Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunology Today, [online] 20(4), pp.158-160. Available at: http://10.1016/s0167-5699(98)01435-2.

  • Journal

    Greiner, J., Bullinger, L., Guinn, B., Dohner, H. and Schmitt, M.

    Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells

    2008 - Clinical Cancer Research

    In-text: (Greiner et al., 2008)

    Your Bibliography: Greiner, J., Bullinger, L., Guinn, B., Dohner, H. and Schmitt, M. (2008). Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells. Clinical Cancer Research, [online] 14(22), pp.7161-7166. Available at: http://10.1158/1078-0432.ccr-08-1102.

  • Journal

    Gross, G., Waks, T. and Eshhar, Z.

    Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

    1989 - Proceedings of the National Academy of Sciences

    In-text: (Gross, Waks and Eshhar, 1989)

    Your Bibliography: Gross, G., Waks, T. and Eshhar, Z. (1989). Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proceedings of the National Academy of Sciences, [online] 86(24), pp.10024-10028. Available at: http://10.1073/pnas.86.24.10024.

  • Journal

    Hinrichs, C. S. and Rosenberg, S. A.

    Exploiting the curative potential of adoptive T-cell therapy for cancer

    2013 - Immunological Reviews

    In-text: (Hinrichs and Rosenberg, 2013)

    Your Bibliography: Hinrichs, C. and Rosenberg, S. (2013). Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunological Reviews, [online] 257(1), pp.56-71. Available at: http://10.1111/imr.12132.

  • Journal

    Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

    2010 - New England Journal of Medicine

    In-text: (Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, 2010)

    Your Bibliography: Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. (2010). New England Journal of Medicine, [online] 363(13), pp.1290-1290. Available at: http://10.1056/nejmx100063.

  • Journal

    Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., Manson, K., Panicali, D. L., Laus, R., Schlom, J., Dahut, W. L., Arlen, P. M., Gulley, J. L. and Godfrey, W. R.

    Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

    2010 - Journal of Clinical Oncology

    In-text: (Kantoff et al., 2010)

    Your Bibliography: Kantoff, P., Schuetz, T., Blumenstein, B., Glode, L., Bilhartz, D., Wyand, M., Manson, K., Panicali, D., Laus, R., Schlom, J., Dahut, W., Arlen, P., Gulley, J. and Godfrey, W. (2010). Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology, [online] 28(7), pp.1099-1105. Available at: http://10.1200/jco.2009.25.0597.

  • Journal

    Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J. and Schreiber, R. D.

    Demonstration of an interferon  -dependent tumor surveillance system in immunocompetent mice

    1998 - Proceedings of the National Academy of Sciences

    In-text: (Kaplan et al., 1998)

    Your Bibliography: Kaplan, D., Shankaran, V., Dighe, A., Stockert, E., Aguet, M., Old, L. and Schreiber, R. (1998). Demonstration of an interferon  -dependent tumor surveillance system in immunocompetent mice. Proceedings of the National Academy of Sciences, [online] 95(13), pp.7556-7561. Available at: http://10.1073/pnas.95.13.7556.

  • Journal

    Keir, M. E., Butte, M. J., Freeman, G. J. and Sharpe, A. H.

    PD-1 and Its Ligands in Tolerance and Immunity

    2008 - Annual Review of Immunology

    In-text: (Keir et al., 2008)

    Your Bibliography: Keir, M., Butte, M., Freeman, G. and Sharpe, A. (2008). PD-1 and Its Ligands in Tolerance and Immunity. Annual Review of Immunology, [online] 26(1), pp.677-704. Available at: http://10.1146/annurev.immunol.26.021607.090331.

  • Journal

    Leach, D. R., Krummel, M. F. and Allison, J. P.

    Enhancement of Antitumor Immunity by CTLA-4 Blockade

    1996 - Science

    In-text: (Leach, Krummel and Allison, 1996)

    Your Bibliography: Leach, D., Krummel, M. and Allison, J. (1996). Enhancement of Antitumor Immunity by CTLA-4 Blockade. Science, [online] 271(5256), pp.1734-1736. Available at: http://10.1126/science.271.5256.1734.

  • Journal

    Littman, D.

    Releasing the Brakes on Cancer Immunotherapy

    2015 - Cell

    In-text: (Littman, 2015)

    Your Bibliography: Littman, D. (2015). Releasing the Brakes on Cancer Immunotherapy. Cell, [online] 162(6), pp.1186-1190. Available at: http://10.1016/j.cell.2015.08.038.

  • Journal

    Mellman, I., Coukos, G. and Dranoff, G.

    Cancer immunotherapy comes of age

    2011 - Nature

    In-text: (Mellman, Coukos and Dranoff, 2011)

    Your Bibliography: Mellman, I., Coukos, G. and Dranoff, G. (2011). Cancer immunotherapy comes of age. Nature, [online] 480(7378), pp.480-489. Available at: http://10.1038/nature10673.

  • Journal

    Morgan, R. A., Dudley, M. E. and Rosenberg, S. A.

    Adoptive Cell Therapy

    2010 - The Cancer Journal

    In-text: (Morgan, Dudley and Rosenberg, 2010)

    Your Bibliography: Morgan, R., Dudley, M. and Rosenberg, S. (2010). Adoptive Cell Therapy. The Cancer Journal, [online] 16(4), pp.336-341. Available at: http://10.1097/ppo.0b013e3181eb3879.

  • Journal

    Palucka, K. and Banchereau, J.

    Cancer immunotherapy via dendritic cells

    2012 - Nature Reviews Cancer

    In-text: (Palucka and Banchereau, 2012)

    Your Bibliography: Palucka, K. and Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nature Reviews Cancer, [online] 12(4), pp.265-277. Available at: http://10.1038/nrc3258.

  • Journal

    Pardoll, D. M. and Topalian, S. L.

    The role of CD4+ T cell responses in antitumor immunity

    1998 - Current Opinion in Immunology

    In-text: (Pardoll and Topalian, 1998)

    Your Bibliography: Pardoll, D. and Topalian, S. (1998). The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology, [online] 10(5), pp.588-594. Available at: http://10.1016/s0952-7915(98)80228-8.

  • Journal

    Qian, X., Wang, X. and Jin, H.

    Cell Transfer Therapy for Cancer: Past, Present, and Future

    2014 - Journal of Immunology Research

    In-text: (Qian, Wang and Jin, 2014)

    Your Bibliography: Qian, X., Wang, X. and Jin, H. (2014). Cell Transfer Therapy for Cancer: Past, Present, and Future. Journal of Immunology Research, [online] 2014, pp.1-9. Available at: http://10.1155/2014/525913 [Accessed 5 Jan. 2018].

  • Journal

    Rosenberg, S. A., Yang, J. C. and Restifo, N. P.

    Cancer immunotherapy: moving beyond current vaccines

    2004 - Nature Medicine

    In-text: (Rosenberg, Yang and Restifo, 2004)

    Your Bibliography: Rosenberg, S., Yang, J. and Restifo, N. (2004). Cancer immunotherapy: moving beyond current vaccines. Nature Medicine, [online] 10(9), pp.909-915. Available at: http://10.1038/nm1100.

  • Journal

    Sharma, P. and Allison, J.

    Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

    2015 - Cell

    In-text: (Sharma and Allison, 2015)

    Your Bibliography: Sharma, P. and Allison, J. (2015). Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential. Cell, [online] 161(2), pp.205-214. Available at: http://10.1016/j.cell.2015.03.030.

  • Journal

    Sharma, P., Wagner, K., Wolchok, J. D. and Allison, J. P.

    Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

    2011 - Nature Reviews Cancer

    In-text: (Sharma et al., 2011)

    Your Bibliography: Sharma, P., Wagner, K., Wolchok, J. and Allison, J. (2011). Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nature Reviews Cancer, [online] 11(11), pp.805-812. Available at: http://10.1038/nrc3153.

  • Journal

    Sharma, P., Wagner, K., Wolchok, J. D. and Allison, J. P.

    Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

    2011 - Nature Reviews Cancer

    In-text: (Sharma et al., 2011)

    Your Bibliography: Sharma, P., Wagner, K., Wolchok, J. and Allison, J. (2011). Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nature Reviews Cancer, [online] 11(11), pp.805-812. Available at: http://10.1038/nrc3153.

  • Journal

    Syn, N. L., Teng, M. W. L., Mok, T. S. K. and Soo, R. A.

    De-novo and acquired resistance to immune checkpoint targeting

    2017 - The Lancet Oncology

    In-text: (Syn et al., 2017)

    Your Bibliography: Syn, N., Teng, M., Mok, T. and Soo, R. (2017). De-novo and acquired resistance to immune checkpoint targeting. The Lancet Oncology, [online] 18(12), pp.e731-e741. Available at: http://10.1016/s1470-2045(17)30607-1 [Accessed 2 Jan. 2018].

  • Journal

    Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., Leming, P. D., Lipson, E. J., Puzanov, I., Smith, D. C., Taube, J. M., Wigginton, J. M., Kollia, G. D., Gupta, A., Pardoll, D. M., Sosman, J. A. and Hodi, F. S.

    Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

    2014 - Journal of Clinical Oncology

    In-text: (Topalian et al., 2014)

    Your Bibliography: Topalian, S., Sznol, M., McDermott, D., Kluger, H., Carvajal, R., Sharfman, W., Brahmer, J., Lawrence, D., Atkins, M., Powderly, J., Leming, P., Lipson, E., Puzanov, I., Smith, D., Taube, J., Wigginton, J., Kollia, G., Gupta, A., Pardoll, D., Sosman, J. and Hodi, F. (2014). Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab. Journal of Clinical Oncology, [online] 32(10), pp.1020-1030. Available at: http://10.1200/jco.2013.53.0105.

  • Journal

    Tran, K. Q., Zhou, J., Durflinger, K. H., Langhan, M. M., Shelton, T. E., Wunderlich, J. R., Robbins, P. F., Rosenberg, S. A. and Dudley, M. E.

    Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell Therapy

    2008 - Journal of Immunotherapy

    In-text: (Tran et al., 2008)

    Your Bibliography: Tran, K., Zhou, J., Durflinger, K., Langhan, M., Shelton, T., Wunderlich, J., Robbins, P., Rosenberg, S. and Dudley, M. (2008). Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell Therapy. Journal of Immunotherapy, [online] 31(8), pp.742-751. Available at: http://10.1097/cji.0b013e31818403d5 [Accessed 8 Jan. 2018].

  • Journal

    Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W.

    Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

    1995 - Science

    In-text: (Waterhouse et al., 1995)

    Your Bibliography: Waterhouse, P., Penninger, J., Timms, E., Wakeham, A., Shahinian, A., Lee, K., Thompson, C., Griesser, H. and Mak, T. (1995). Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4. Science, [online] 270(5238), pp.985-988. Available at: http://10.1126/science.270.5238.985.

  • Journal

    Yaddanapudi, K., Mitchell, R. A. and Eaton, J. W.

    Cancer vaccines

    2013 - OncoImmunology

    In-text: (Yaddanapudi, Mitchell and Eaton, 2013)

    Your Bibliography: Yaddanapudi, K., Mitchell, R. and Eaton, J. (2013). Cancer vaccines. OncoImmunology, [online] 2(3), p.e23403. Available at: http://10.4161/onci.23403.

  • Journal

    Yee, C.

    Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?

    2013 - Clinical Cancer Research

    In-text: (Yee, 2013)

    Your Bibliography: Yee, C. (2013). Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?. Clinical Cancer Research, [online] 19(17), pp.4550-4552. Available at: http://10.1158/1078-0432.ccr-13-1367.

  • Journal

    zur Hausen, H.

    Papillomaviruses in the causation of human cancers — a brief historical account

    2009 - Virology

    In-text: (zur Hausen, 2009)

    Your Bibliography: zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers — a brief historical account. Virology, [online] 384(2), pp.260-265. Available at: http://10.1016/j.virol.2008.11.046.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Super fast and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use our extensive Premium features (Plagiarism checks, Word Add On...)
  • ✔ Create and edit multiple bibliographies
Join